Market Access Pathway for Medical Nutrition in Europe and The Us von Chevrou, Séverac H, Droeschel, D, Walzer, S

Volltext

Health economics evidence for medical nutrition: are these interventions value for money in integrated care? von Walzer, Stefan, Droeschel, Daniel, Nuijten, Mark, Chevrou-Séverac, Hélène

Volltext

Nutrition Pharmaco-Economics: Specificities And Challenges von Amzal, B, Chevrou-Severac, H

Volltext

Health economic analyses in medical nutrition: a systematic literature review von Walzer, Stefan, Droeschel, Daniel, Nuijten, Mark, Chevrou-Séverac, Hélène

Volltext

Systematic Review: The Economic Burden of Crohn’s Disease in Europe in Adults and Children von Floyd, D, Langham, S, Chevrou-Severac, H

Volltext

Health Economic Evidence for Medical Nutritions: Are These Interventions Value for Money? von Walzer, S, Droeschel, D, Nuijten, M.J.C, Chevrou-Severac, H

Volltext

Health Economic Analyses in Medical Nutrition: A Systematic Literature Review von Walzer, S, Droeschel, D, Nuijten, M.J.C, Chevrou-Severac, H

Volltext

PCN41 Cost-Effectiveness Analysis of Immunonutrition for Upper Gastrointestinal Cancer Patients Undergoing Surgery in British Hospitals von Chevrou-Severac, H, Eijgelshoven, I, Weijers, L

Volltext

PHP146 - Market Access Pathway for Medical Nutrition in Europe and The Us von Chevrou, Séverac H., Droeschel, D., Walzer, S.

Volltext

Economic Grand Rounds: Financial Burden of Medical Care and Risk of Forgoing Care Among Europeans With Depressive Symptoms von Peytremann-Bridevaux, Isabelle, Chevrou-Severac, H

Volltext

PP101-SUN COST-EFFECTIVENESS ANALYSIS OF IMMUNONUTRITION FOR UPPER GASTROINTESTINAL CANCER PATIENTS UNDERGOING SURGERY IN BRITISH HOSPITALS von Chevrou-Severac, H, Weijers, L, Eijgelshoven, I

Volltext

PF552 PATIENT‐REPORTED OUTCOME MEASURES IN CLINICAL STUDIES FOR MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA: A LITERATURE REVIEW AND LANDSCAPE ANALYSIS von Chevrou‐Séverac, H., Lambert, J., Savre, I., Koochaki, P., Gaugler, L., Stojkov, I., Siebert, U., Stauder, R.

Volltext

PATIENT-REPORTED OUTCOME MEASURES IN CLINICAL STUDIES FOR MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA: A LITERATURE REVIEW AND LANDSCAPE ANALYSIS: PF552 von Chevrou-Séverac, H., Lambert, J., Savre, I., Koochaki, P., Gaugler, L., Stojkov, I., Siebert, U., Stauder, R.

Volltext

Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category? von Adkins, Elizabeth M, Nicholson, Lindsay, Floyd, David, Ratcliffe, Mark, Chevrou-Severac, Helene

Volltext

PP071-SUN IMMUNONUTRITION FOR GASTROINTESTINAL CANCER PATIENTS: AN EFFECTIVE AND COST-SAVINGS INTERVENTION von Chevrou-Severac, H, Mauskopf, J, Candrilli, S, Ochoa, J.B

Volltext

Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review von Olariu, Elena, Cadwell, Kevin K, Hancock, Elizabeth, Trueman, David, Chevrou-Severac, Helene

Volltext

Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK von Wilson, Michele R, Azzabi Zouraq, Ismail, Chevrou-Severac, Helene, Selby, Ross, Kerrigan, Matthew C

Volltext

PHP146 - Nutrition Pharmaco-Economics: Specificities And Challenges von Amzal, B., Chevrou-Severac, H.

Volltext

PTH-084 Cost-Effectiveness of Vedolizumab Compared with Infliximab, Adalimumab, and Golimumab for Treatment of Moderately-to-Severely Active Ulcerative Colitis in The United Kingdo... von Wilson, M, Kerrigan, M, Smyth, M, Chevrou-Severac, H, Bergman, A, Selby, R

Volltext

PTH-083 Cost-Effectiveness of Vedolizumab Compared with Conventional Therapy for Treatment of Moderately-to-Severely Active Ulcerative Colitis in The United Kingdom von Wilson, M, Kerrigan, M, Smyth, M, Chevrou-Severac, H, Bergman, A, Selby, R

Volltext